- 1D
- 3D
- 1W
- 1M
- 6M
- 1Y
- 3Y
- 5Y
Announcements
- Fireside Panel Discussion on Diabetes sector
- Arecor and Sequel Med Tech to host fireside panel
- Holding(s) in Company
- Enhanced IP Coverage: AT278 & Oral Peptide Program
- Directorate Changes
- Interim results for the six months to 30 June 2025
- Co-Development Agreement & Monetisation Deal
- Notice of Interim Results
- Positive FDA Feedback on Phase 2 Study Design
- Change of Auditor
More ▼
Key statistics
On Friday, Arecor Therapeutics PLC (AREC:LSE) closed at 77.50, -22.50% below its 52-week high of 100.00, set on Sep 25, 2025.
52-week range
| Open | 77.50 |
|---|---|
| High | 80.50 |
| Low | 77.50 |
| Bid | 75.00 |
| Offer | 90.00 |
| Previous close | 77.50 |
| Average volume | 10.44k |
|---|---|
| Shares outstanding | 37.76m |
| Free float | 17.90m |
| P/E (TTM) | -- |
| Market cap | 29.26m GBP |
| EPS (TTM) | -0.2208 GBP |
Data delayed at least 20 minutes, as of Feb 06 2026 10:41 GMT.
More ▼
